Retrospective analysis on the efficacy of botulinum toxin alone versus combined botulinum toxin and topical diltiazem

The study demonstrates that BT is an effective and safe treatment for CAF, with or without the addition of TD. The combination therapy did not show superior outcomes.

Authors

Institutions

Publication Details

Journal
International Journal of Colorectal Disease
Published
2025-02-26
DOI
https://doi.org/10.1007/s00384-025-04823-y
Primary Topic
Botulinum Toxin and Related Neurological Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Retrospective analysis on the efficacy of botulinum toxin alone versus combined botulinum toxin and topical diltiazem

Mustafa Öncel, Yasemin Yildirim, Naci̇ye Çiğdem Arslan, Erdal Karagöz et al.
International Journal of Colorectal Disease
Botulinum Toxin and Related Neurological Disorders
article

Retrospective analysis on the efficacy of botulinum toxin alone versus combined botulinum toxin and topical diltiazem

Mustafa Öncel, Yasemin Yildirim, Naci̇ye Çiğdem Arslan, Erdal Karagöz, Tansu Altıntaş, Caglar Kazim Pekuz
article en

Abstract

The study demonstrates that BT is an effective and safe treatment for CAF, with or without the addition of TD. The combination therapy did not show superior outcomes.

International Journal of Colorectal DiseaseVol. 40(1)
Istanbul Medipol University (TR), Istinye University (TR)
Zero hunger
Openalex Percentile: Top 94%
Botulinum Toxin and Related Neurological Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.